Interpore buys OsteoMedix in cash and share deal
This article was originally published in Clinica
Executive Summary
Interpore Cross International is to pay $8 million in cash and give roughly 2.4 million shares for American OsteoMedix (AOM), a privately-owned minimally invasive device company. The company produces the AOM-CDO system, a placement system for reinforcement substances inside the vertebrae, to repair compression fractures caused by osteoporosis damage.